Cargando…
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs in adults following SARS-CoV-2 vaccinations....
Autores principales: | Nune, Arvind, Durkowski, Victor, Pillay, S. Sujitha, Barman, Bhupen, Elwell, Helen, Bora, Kaustubh, Bilgrami, Syed, Mahmood, Sajid, Babajan, Nasarulla, Venkatachalam, Srinivasan, Ottewell, Lesley, Manzo, Ciro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610967/ https://www.ncbi.nlm.nih.gov/pubmed/37896974 http://dx.doi.org/10.3390/vaccines11101571 |
Ejemplares similares
-
Post-COVID-19 Condition and İts Recognition in Low- and Middle-income Countries: Working Notes from the United Kingdom Experience
por: Nune, Arvind, et al.
Publicado: (2022) -
“Living with COVID”—implications for immunosuppressed and immunocompromised
por: Nune, A., et al.
Publicado: (2022) -
Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder
por: Manzo, Ciro, et al.
Publicado: (2023) -
Marijuana smoking: a possible cause of diffuse alveolar hemorrhage
por: Barman, Bhupen, et al.
Publicado: (2020) -
A cross-sectional study of the mental health burden among COVID-19 survivors
por: Nongpiur, Arvind, et al.
Publicado: (2023)